🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Pacific Biosciences of California, Inc.

PACB Healthcare
$2.06 $-0.08 (-3.74%)
Market Cap: $640.31 M
Gurus Holding
7
Popularity Rank
#1212
% of Shares Held
12.11%
Net Activity (Q2 2026)
-$4.83 M

Guru Ownership Trend

Guru Analysis for Pacific Biosciences of California, Inc. (PACB)

Pacific Biosciences of California, Inc. (PACB), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $77.52 M.

Top institutional holders include Catherine Wood and Steven Cohen.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.83 M net outflow during the quarter.

Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Renaissance Technologies (RenTech) reduced exposure by 61.2%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$8.64 M
Total Buy Value
New Buys 1
Additions 2
-$13.47 M
Total Sell Value
Reductions 3
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
3

FAQs for Pacific Biosciences of California, Inc. (PACB)

Major holders include Catherine Wood ($50.03 M), Steven Cohen ($8.04 M), Cliff Asness ($2.18 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 37.63 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.83 M, with 3 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited PACB. The total reported sell value was $13.47 M.

Yes, 1 managers opened new positions in PACB, and 2 increased their existing holdings. The total reported buy value was $8.64 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.32% Reduce -17.9% 29,781,416 $50.03 M Q2 2026
0.01% Add 1575.6% 4,787,300 $8.04 M Q2 2026
0.00% Add 70.7% 1,296,684 $2.18 M Q2 2026
0.00% Reduce -61.2% 966,200 $1.62 M Q2 2026
0.00% 684,707 $1.15 M Q2 2026
0.00% New Buy 102,761 $172,638 Q2 2026
0.00% Reduce -4.6% 10,068 $16,914 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form